Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists

A method of treating fatty liver disease, comprising administering to a subject in need thereof, a therapeutically effective amount of a compound of Formula Id, thereby treating the fatty liver disease, wherein the compound of Formula Id has the structure:

• wherein
• each R1a is independently H, C1-6 alkyl, halogen, or C1-6 haloalkyl;
• R2 is H, or C1-6 alkyl;
• and
• each R4 is H, C1-6 alkyl, halogen, or C1-6 haloalkyl;
• and salts and isomers thereof.